Brainstem networks including those ascending from the LC and the raphe nuclei are highly susceptible to neurodegenerative diseases, including AD [79–82], and phosphorylated-tau has been used as a marker of neurodegeneration in diseases such as Alzheimer’s disease and related dementias (ADRD) [83–86]. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.